ENTRY       D03065                      Drug
NAME        Becaplermin (USAN/INN);
            Regranex (TN)
PRODUCT     REGRANEX (Smith & Nephew)
SEQUENCE    SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC
            RPTQVQLRPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT
  TYPE      Peptide
REMARK      ATC code: A01AD08 D03AX06
            Product: D03065<US>
EFFICACY    Anti-ulcerative (skin)
  DISEASE   Diabetic neuropathic ulcers [DS:H01459]
COMMENT     recombinant platelet-derived growth factor BB (PDGF-BB)
TARGET      PDGFRB [HSA:5159] [KO:K05089]
  PATHWAY   hsa04010(5159)  MAPK signaling pathway
            hsa04510(5159)  Focal adhesion
            hsa04540(5159)  Gap junction
            hsa04810(5159)  Regulation of actin cytoskeleton
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AD Other agents for local oral treatment
                 A01AD08 Becaplermin
                  D03065  Becaplermin (USAN/INN) &lt;US&gt;
             D DERMATOLOGICALS
              D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
               D03A CICATRIZANTS
                D03AX Other cicatrizants
                 D03AX06 Becaplermin
                  D03065  Becaplermin (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Wound Care Agents
                Becaplermin
                 D03065  Becaplermin (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               PDGFR family
                PDGFRB
                 D03065  Becaplermin (USAN/INN) &lt;US&gt;
DBLINKS     CAS: 165101-51-9
            PubChem: 17397220
///
